Credit Suisse Investment Banking Pitch Book
Premiums paid on selected precedent transactions
100% cash consideration, transaction value >$2 billion
(U38 in millions)
Ann.
Date Target
09/03/12 Medicle Pharmaceutical Corp
07/23/12 Nexen Inc.
07/09/12 Amerigroup Corp
07/01/12 Lincare Holdings inc
06/29/12 Amylin Pharmaceuticals Inc
04/19/12 Human Genome Sciences inc
01/07/12 Inhibitex inc
09/12/11 NetLogic Microsystems
08/15/11 Motorola Mobility Holdings Inc
07/15/11 Petrohawk Energy Corp
06/23/11
Southern Union Co
The Timberland Co
06/13/11
06/06/11
Temple-Inland Inc
05/06/11
Warner Music Group Corp
05/04/11
Varlan Semiconductor Equip
04/04/11 National Semiconductor Corp
03/28/11
GSI Commerce inc
02/07/11
Beckman Coulter Inc
11/30/10
Baldor Electric Co
11/15/10 Bucyrus International Inc
10/12/10 King Pharmaceuticals inc
08/23/10 SPAR Inc
08/19/10 McAfee Inc
05/12/10 Sybase inc
03/01/10
OSI Pharmaceuticals inc
02/28/10 Millipore Corp
11/11/09 3Com Corp
09/21/09 Perot Systems Corp
04/20/09
Sun Microsystems inc
10/02/08
Atmel Corp
07/14/08 Republic Services Inc
07/14/08 Duvernay Oll Corp
07/10/08 Rohm & Haas Co
05/13/08 Electronic Data Systems Corp
Diebold Inc
03/03/08
02/21/08 ChoicePoint Inc
12/10/07 Adams Respiratory Therapeutics
11/26/07 Genlyte Group Inc
10/15/07
Tektronix Inc
Source:
Note:
Acquiror
Valeant Pharm Inti Inc
CNOOC
WellPoint Inc
Linde AG
Bristol-Myers Squibb Co
GlaxoSmithKline PLC
Bristol-Myers Squibb Co
Broadcom Corp.
Google Inc
BHP Billiton PLC
The Williams Cos Inc
VF Enterprises Inc
International Paper Co
CREDIT SUISSE
Access Industries Inc
Applied Materials
Texas Instruments Inc
eBay Inc.
Danaher Corp
ABB Ltd
Caterpillar Inc
Pfizer Inc
Hewlett-Packard Co
Intel
SAP
Astellas Pharma Inc
Merck KGaA
Hewlett-Packard Co
Dell Inc
Oracle Corp
Microchip Technology Inc
Waste Management Inc
Royal Dutch Shell
Dow Chemical Co
Hewlett-Packard Co
United Technologies Corp
Reed Elsevier Group PLC
Reckitt Benckiser PLC
Philips Holding USA Inc
Danaher Corp
SDC Platinum, FactSet Research Systems.
Highlighted deals represent E&P transactions.
Premium to unaffected spot prices.
Trans.
Value
$3,074
17,743
4,852
3,689
7,183
2,910
2,524
3,678
11,878
15,068
5,520
2,181
3,582
3,306
4,715
6,360
2,279
5,782
4,188
7,453
3,566
2,065
7,828
6,149
3,100
6,127
3,183
3,628
7,305
2,249
7,016
5,838
15,513
12,565
2,632
3,790
2,267
2,810
2,956
1-Day
39.4%
61.2%
43.0%
64.3%
101.4%
98.7%
163.4%
56.7%
63.5%
65.0%
55.7%
43.4%
47.5%
74.8%
55.4%
77.7%
50.9%
46.3%
40.8%
32.2%
40.4%
82.9%
60.4%
56.4%
55.3%
50.0%
38.8%
67.5%
42.0%
52.4%
32.6%
42.0%
74.0%
32.6%
65.8%
48.5%
37.4%
52.4%
34.1%
5-Day
34.5%
66.0%
39.6%
61.2%
103.1%
92.3%
137.7%
67.3%
85.8%
57.7%
50.2%
45.8%
30.6%
56.8%
34.5%
73.3%
49.3%
42.8%
41.5%
27.7%
40.3%
83.3%
60.2%
53.0%
55.2%
54.9%
44.7%
74.6%
48.0%
37.4%
29.3%
51.2%
72.3%
29.8%
55.3%
46.0%
38.6%
46.7%
31.9%
10-Day
34.0%
67.1%
45.8%
66.7%
97.7%
79.9%
137.4%
74.0%
82.2%
57.1%
48.6%
32.2%
38.8%
53.1%
46.0%
78.6%
59.0%
50.5%
42.7%
36.5%
43.5%
223.9%
47.6%
50.5%
62.1%
57.5%
45.2%
80.1%
11.9%
31.6%
24.6%
37.0%
59.0%
31.9%
60.4%
52.4%
45.0%
43.9%
36.1%
Premium to (¹)
20-Day
33.5%
73.7%
47.2%
82.2%
81.4%
85.1%
86.2%
58.4%
84.4%
63.6%
55.9%
27.6%
31.2%
50.3%
30.0%
70.2%
40.7%
49.0%
50.6%
23.6%
53.2%
244.8%
52.0%
38.1%
68.0%
51.1%
38.8%
76.5%
17.3%
26.3%
9.3%
34.3%
53.3%
47.2%
47.4%
55.3%
39.0%
65.7%
19.4%
30-Day
33.1%
74.5%
47.2%
81.5%
73.5%
75.9%
86.2%
58.4%
89.4%
62.1%
58.9%
26.9%
33.2%
50.3%
33.2%
61.2%
40.4%
48.9%
51.1%
23.8%
52.1%
254.8%
56.0%
38.1%
69.9%
50.0%
38.6%
76.5%
17.3%
21.7%
9.3%
34.3%
51.1%
44.9%
54.7%
56.9%
39.1%
64.4%
19.8%
60-Day
33.1%
74.5%
47.2%
81.5%
73.5%
75.9%
86.2%
58.4%
89.4%
62.1%
58.9%
26.9%
33.2%
50.3%
33.2%
61.2%
40.4%
48.9%
51.1%
23.8%
52.1%
254.8%
56.0%
38.1%
69.9%
50.0%
38.6%
76.5%
17.3%
21.7%
9.3%
34.3%
51.1%
44.9%
54.7%
56.9%
39.1%
19.8%
52wk high
9.7%
10.0%
22.4%
36.5%
68.0%
(52.5%)
57.7%
14.4%
9.5%
41.2%
44.3%
(5.9%)
18.3%
2.9%
25.0%
56.3%
(6.7%)
19.5%
38.7%
21.2%
8.0%
82.1%
5.1%
34.9%
44.4%
43.6%
33.9%
59.4%
(42.0%)
(14.2%)
5.7%
22.8%
24.4%
(14.2%)
(26.6%)
12.9%
28.6%
8.6%
7.4%
Confidential
9View entire presentation